Register Now: IKRIS Breast Cancer Awareness Run 2022

Search results for:covid

Nirmatrelvir / Ritonavir

What is Nirmatrelvir Ritonavir, and what it is used for? The FDA has issued an EUA for the emergency use […]

ikrisuser
April 15, 2022

Remdesivir

WHAT IS REMDESIVIR AND WHAT IT IS USED FOR: REMDESIVIR is basically an adenosine nucleoside triphosphate analog. Which was originally […]

ikrisuser
December 7, 2020

Relations of India and Ghana: Healthcare and pharmaceutical sector

India bags the title of the largest provider of generic medicines globally. The country has a share of 20% of […]

ikrisuser
July 29, 2022

Overview of Healthcare Sector of Burundi; an East African country

Burundi is an East African country, officially known as the Republic of Burundi. Burundi has the severest hunger and malnourishment […]

ikrisuser
April 27, 2022

Contract Manufacturing/Private Label Manufacturing

Due to the impact of COVID-19, the pharmaceutical sector sought contract manufacturing in a big way. Its growth from USD […]

ikrisuser
July 28, 2021

Olumiant (Baricitinib): A New Medicine in The Town for Alopecia Areata

On June 13, 2022, the U.S. Food and Drug Administration (FDA) announced it has approved oral tablets of Olumiant (baricitinib) […]

ikrisuser
June 21, 2022

Ikris Pharmaceutical in Brazil Health sector

We, Ikris Pharma Network are International pharmaceutical distributors from India. We supply products to all the people involved in the […]

ikrisuser
October 20, 2021

Third-party pharmaceutical manufacturing

Third-party pharma manufacturing facilitates a bridge between the manufacturer and the organization/ hospitals in need of a product with standard […]

ikrisuser
October 20, 2021

Pharmaceutical wholesale distributors in the Health sector

The pharmaceutical industry is changing rapidly. Due to increasing chronic diseases and after the Covid-19 outbreak, there came a massive […]

ikrisuser
October 25, 2021

FDA Approves Opzelura (Ruxolitinib) Cream for Vitiligo in Patients Aged 12 Years and Older

On July 19, 2022, the FDA approved Opzelura (ruxolitinib), the first and only topical treatment for non-segmental vitiligo in adult […]

ikrisuser
July 28, 2022